The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Research Institute for Tropical Medicine, Manila, Philippines.
HIV Med. 2019 Mar;20(3):183-191. doi: 10.1111/hiv.12687. Epub 2019 Jan 8.
With aging of the HIV-positive population, cardiovascular disease (CVD) increasingly contributes to morbidity and mortality. We investigated CVD-related and other causes of death (CODs) and factors associated with CVD in a multi-country Asian HIV-positive cohort.
Patient data from 2003-2017 were obtained from the Therapeutics, Research, Education and AIDS Training in Asia (TREAT Asia) HIV Observational Database (TAHOD). We included patients on antiretroviral therapy (ART) with > 1 day of follow-up. Cumulative incidences were plotted for CVD-related, AIDS-related, non-AIDS-related, and unknown CODs, and any CVD (i.e. fatal and nonfatal). Competing risk regression was used to assess risk factors of any CVD.
Of 8069 patients with a median follow-up of 7.3 years [interquartile range (IQR) 4.4-10.7 years], 378 patients died [incidence rate (IR) 6.2 per 1000 person-years (PY)], and this total included 22 CVD-related deaths (IR 0.36 per 1000 PY). Factors significantly associated with any CVD event (IR 2.2 per 1000 PY) were older age [sub-hazard ratio (sHR) 2.21; 95% confidence interval (CI) 1.36-3.58 for age 41-50 years; sHR 5.52; 95% CI 3.43-8.91 for ≥ 51 years, compared with < 40 years], high blood pressure (sHR 1.62; 95% CI 1.04-2.52), high total cholesterol (sHR 1.89; 95% CI 1.27-2.82), high triglycerides (sHR 1.55; 95% CI 1.02-2.37) and high body mass index (BMI) (sHR 1.66; 95% CI 1.12-2.46). CVD crude IRs were lower in the later ART initiation period and in lower middle- and upper middle-income countries.
The development of fatal and nonfatal CVD events in our cohort was associated with older age, and treatable risk factors such as high blood pressure, triglycerides, total cholesterol and BMI. Lower CVD event rates in middle-income countries may indicate under-diagnosis of CVD in Asian-Pacific resource-limited settings.
随着 HIV 阳性人群的老龄化,心血管疾病(CVD)越来越成为发病率和死亡率的主要原因。我们调查了一个多国家亚洲 HIV 阳性队列中与 CVD 相关的其他死亡原因(CODs)和与 CVD 相关的因素。
2003 年至 2017 年从治疗、研究、教育和艾滋病培训在亚洲(TREAT Asia)艾滋病毒观察数据库(TAHOD)获得患者数据。我们纳入了接受抗逆转录病毒治疗(ART)且随访时间超过 1 天的患者。绘制了与 CVD 相关、艾滋病相关、非艾滋病相关和未知 CODs 以及任何 CVD(即致命和非致命)的累积发生率,并使用竞争风险回归来评估任何 CVD 的危险因素。
在中位随访 7.3 年[四分位间距(IQR)4.4-10.7 年]的 8069 例患者中,有 378 例患者死亡[发生率(IR)为 6.2 例/1000 人年(PY)],总死亡人数包括 22 例 CVD 相关死亡(IR 为 0.36 例/1000 PY)。与任何 CVD 事件显著相关的因素(IR 为 2.2 例/1000 PY)为年龄较大[亚危险比(sHR)2.21;年龄 41-50 岁的 95%置信区间(CI)为 1.36-3.58;年龄≥51 岁的 sHR 为 5.52;95%CI 为 3.43-8.91,与<40 岁相比]、高血压(sHR 1.62;95%CI 为 1.04-2.52)、总胆固醇高(sHR 1.89;95%CI 为 1.27-2.82)、甘油三酯高(sHR 1.55;95%CI 为 1.02-2.37)和高体质指数(BMI)(sHR 1.66;95%CI 为 1.12-2.46)。晚期 ART 起始期和中低收入国家的 CVD 粗发病率较低。
我们队列中致命和非致命 CVD 事件的发生与年龄较大以及可治疗的危险因素(如高血压、甘油三酯、总胆固醇和 BMI)有关。在中等收入国家,CVD 事件发生率较低可能表明亚太资源有限地区对 CVD 的诊断不足。